EUCTR2007-002846-38-BG进行中（未招募）不适用
A Multicenter, Open-Label, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of Combretastatin A-4 Phosphate in Combination with Paclitaxel and Carboplatin in comparison with Paclitaxel and Carboplatin against Anaplastic Thyroid Carcinoma - NA
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Anaplastic thyroid carcinoma histologically or cytologically confirmed pathology, having been refractory to or progressed during or after therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Tumors confined to the thyroid or an uncontrolled active infection or clinically evident brain metastasis
研究者
相似试验
Unknown
2 期
A Clinical study to evaluate the effect of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin in Comparison With Paclitaxel and Carboplatin in Anaplastic Thyroid Carcinoma patients.CTRI/2009/091/000057Oxigene Inc180
进行中（未招募）
1 期
A Randomized Trial of Standard Treatment with Cabazitaxel Once Every Three Weeks Compared to a Regimen of Cabazitaxel Given Weekly for Five of Six Consecutive Weeks in Patients With Prostate Cancer that has SpreadMetastatic Castration Resistant Prostate CancerMedDRA version: 14.1Level: LLTClassification code 10062904Term: Hormone-refractory prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10036920Term: Prostate cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-004178-27-SEKarolinska University Hospital130
进行中（未招募）
1 期
Study to investigate the function of three medicinal products (monoclonal antibodies) on a population of patients with colorectal cancer that has spread from its site of origin to another part of the body.Metastatic Colorectal CarcinomaEUCTR2018-000618-39-ESSymphogen A/S54
进行中（未招募）
1 期
Study to investigate the function of three medicinal products (monoclonal antibodies) on a population of patients with colorectal cancer that has spread from its site of origin to another part of the body.EUCTR2018-000618-39-ITSYMPHOGEN A/S54
进行中（未招募）
1 期
A Phase IIb study to Evaluate the Safety, Tolerability and Efficacy of IZD174 in Patients with Cryopyrin-Associated Periodic SyndromesEUCTR2020-000489-40-GBInflazome (Australia) Pty Ltd.14